GL1X · GenesisL1 explorer

Research workbench

Crystal structure of bptf bromodomain with a selective inhibitor

Analyse Crystal structure of bptf bromodomain with a selective inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7RWO
Type
protein
Length
119 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nucleosome-remodeling factor subunit bptf
UniProt
Q12830
Ligands
7WN
Pockets
1 · best druggability 0.49

Structure

x-ray diffraction · 1 distinct chain · 72% helix, 2% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANucleosome-remodeling factor subunit bptfprotein11972% helix, 2% strandQ12830

Ligands and binding sites

  • 7WN · 4-chloro-2-methyl-5-[(1,2,3,4-tetrahydroisoquinolin-7-yl)amino]pyridazin-3(2H)-one · ligand · chains A
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1810.490.83197WN

Compared structures

  • 7RWO · Crystal Structure of BPTF bromodomain in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.